Announcements Trials

Browse Landscape

Phase

Phase 3 8 Phase 2 6 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 9 Cancer Pain 5 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Agnosia 3 Rectal Neoplasms 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Prostatic Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Pleural Effusion, Malignant 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Ileus 1 Failed Back Surgery Syndrome 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Arrhythmias, Cardiac 1

Interventions

Dexamethasone 8 Oxycodone 6 Epoetin Alfa 5 Propofol 4 Palonosetron 4 Meropenem 4 Zoledronic Acid 3 Vancomycin 3 Sevoflurane 3 Ondansetron 3 Naloxone 3 Everolimus 3 Ciprofloxacin 3 Cholecalciferol 3 Ceftazidime 3 Cefepime 3 Calcium Dobesilate 3 Bevacizumab 3 Aspirin 3 Aprepitant 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vincristine 2 Tobacco Use Cessation Devices 2 Teicoplanin 2 Tablets 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Fentanyl × Clear all

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed

518 enrolled 11 charts

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡